Patent classifications
C07C233/02
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):
##STR00001##
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):
##STR00001##
Methods for inhibiting conversion of choline to trimethylamine (TMA)
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I): ##STR00001##
Methods for inhibiting conversion of choline to trimethylamine (TMA)
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I): ##STR00001##
Indene derivatives and uses thereof
The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
Indene derivatives and uses thereof
The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
THYROMIMETICS
Compounds provided herein function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their preparation.
Method for assessing a state of a living cell
A method for assessing a state of a living cell using surface enhanced Raman spectroscopy (SERS) is provided. The method may include modifying one or more living eel Is with an alkyne-containing compound to form one or more modified living cells, mixing the one or more modified living cells with a SERS-active material to form a mixture, injecting the mixture into a conduit defined by an inner wall of a hollow core photonic crystal fiber, and detecting a surface enhanced Raman signal from the mixture in the conduit. In preferred embodiments, the alkyne containing compound is linoleamide alkyne (LLA) for the detection of lipid peroxidation or 4-(dihydroxyborophenyl) acetylene (DBA) for the detection of sialic acid expression in cells, both using gold nanoparticles as the SERS-active material.
Method for assessing a state of a living cell
A method for assessing a state of a living cell using surface enhanced Raman spectroscopy (SERS) is provided. The method may include modifying one or more living eel Is with an alkyne-containing compound to form one or more modified living cells, mixing the one or more modified living cells with a SERS-active material to form a mixture, injecting the mixture into a conduit defined by an inner wall of a hollow core photonic crystal fiber, and detecting a surface enhanced Raman signal from the mixture in the conduit. In preferred embodiments, the alkyne containing compound is linoleamide alkyne (LLA) for the detection of lipid peroxidation or 4-(dihydroxyborophenyl) acetylene (DBA) for the detection of sialic acid expression in cells, both using gold nanoparticles as the SERS-active material.
NON-IONIC DEEP EUTECTIC MIXTURES FOR USE AS SOLVENTS AND DISPERSANTS
Use of a non-ionic deep eutectic mixture consisting of A and B, A being R1R2NCONR3R4 and B being selected from the group consisting of R5R6NCOCH3 and R7R8NCONR9R10, and wherein each of R1-R10 is independently H, CH3 or alkyl, as a solvent or dispersant in chemical synthesis, material synthesis or fabrication, chemical or enzymatic catalysis, food, cosmetic or pharmaceutical formulation, separation or partitioning, heat transfer, and as detergents or cleaners, as well as such mixtures, is disclosed.